Advagene Biopharma Co., Ltd. (TPEX:6709)
28.35
+2.00 (7.59%)
Jan 22, 2026, 1:52 PM CST
35.65% (1Y)
| Market Cap | 1.56B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -71.10M |
| Shares Out | 59.38M |
| EPS (ttm) | -1.23 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 181,218 |
| Average Volume | 47,808 |
| Open | 26.50 |
| Previous Close | 26.35 |
| Day's Range | 26.35 - 29.25 |
| 52-Week Range | 15.75 - 41.00 |
| Beta | 0.67 |
| RSI | 38.99 |
| Earnings Date | Mar 20, 2026 |